Abstract
As the effects of sildenafil are in part mediated by enhancing the action of nitric oxide and nitrates given acutely markedly reduce early wave reflection, we explored the effects of a single oral dose of sildenafil citrate (50 mg) on blood pressure and arterial wave reflection in treated hypertensive men in a single-blind randomised placebo controlled crossover study. Eight men (aged 57–76 years) with well controlled hypertension and erectile dysfunction and no contraindications to the use of sildenafil, were given either sildenafil 50 mg or placebo orally, with the second drug being given 2 weeks later. Blood pressure and heart rate with an automated digital oscillometric device (Omron® HEM-705 CP) and the augmentation index, a measure of arterial wave reflection in the aorta derived using radial applanation tonometry, were measured before and at 15-min intervals for 2 h thereafter. The extent of individual maximum reductions (mm Hg) from baseline in systolic (24 ± 10 vs 6 ± 8, P < 0.05) and diastolic blood pressure (8 ± 5 vs 3 ± 2, P < 0.05) occurred on the sildenafil study day. On average the brachial blood pressure at 75 min following sildenafil was 17/11 mm less than on the placebo day (P < 0.01). Augmentation index was also reduced significantly at 90 min (P < 0.05) suggesting reduced vascular tone in the arteries. The area under the brachial and aortic blood pressure and augmentation index time curve (by the trapezoidal rule corrected for baseline reading) was significantly lower (P < 0.05) on the sildenafil study day. The study shows that the peripheral vasodilatory effects of sildenafil, possibly related to nitric oxide, are accompanied by a fall in systemic blood pressure and reduced arterial wave reflection.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Cheitlin MD et alUse of sildenafil (Viagra) inpatients with cardiovascular disease. ACC.AHA Expert Consensus Document Circulation 1999 99 168–177
Tomlinson JM Viagra and its use in cardiovascular disease J Hum Hypertens 1999 13 593–594
Kloner RA Cardiovascular risk with sildenafil Am J Cardiol 2000 36 (Suppl) 57F–61F
Shakir SA et alCardiovascular events in users of sildenafil: results from first phase of prescription event monitoring in England BMJ 2001 322 651–652
European Agency for Evaluation of Medicinal Products, Committee for Proprietary Medicinal Products European Public Assessment Report: Viagra, CPMP 1136/98, London 1998
Jackson G, Benjamin N, Jackson N, Allen MJ Effect of Sildenafil citrate on human haemodynamics Am J Cardiol 1999 83 13–20C
Morales A et alClinical safety of oral Sildenafil citrate (Viagra) in the treatment of erectile dysfunction Int J Impot Res 1998 10 69–74
Westling H, Hansson L, Jenson B, Nilsen R Vasoactive drugs and elastic properties of human arteries in vivo, with special reference to the action of nitroglycerine Eur Heart J 1984 5 609–616
Breithaupt-Grogler K, Belz GG Epidemiology of the arterial stiffness Pathol Biol 1999 47 604–613
O’Rourke MF, Kelly RP, Avolio AP (Eds) The Arterial Pulse Lea & Febiger: London 1992 pp 36–37
O’Rourke MF, Kelly RP Wave reflection in the circulation and its implications in ventricular function J Hypertens 1993 11 327–337
O’Rourke MF, Gallagher DE Pulse wave analysis J Hypertens 1996 14 (Suppl 5) S147–S157
Kelly R et alNon-invasive registration of the arterial pressure pulse waveform using high-fidelity applanation tonometry J Vasc Med Biol 1989 1 142–149
Karamanoglu M, O’Rourke MF, Avolio AP, Kelly RP An analysis of the relationship between central aortic and peripheral upper limit pressure wave in man Eur Heart J 1993 14 160–167
O’Rourke M Arterial stiffening and ventricular/vascular interaction J Hum Hypertens 1994 8 (Suppl 1) S1–S15
Kelly RP et alNitroglycerin has more favourable effects on left ventricular afterload than apparent from measurement of pressure in a peripheral artery Eur Heart J 1990 11 138–144
Viagra (sildenafil citrate) package insert. NY Pfizer Inc: New York 1998
Wilkinson IB et alReproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis J Hypertens 1998 16 2079–2084
Siebenhofer A, Kemp CRW, Sutton AJ, Williams B The reproducibility of central aortic blood pressure measurements in healthy subjects using applanation tonometry and sphygmocardiography J Hum Hypertens 1999 13 625–629
Boolell M et alSildenafil, an orally active Type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penal erectile dysfunction Int J Impot Res 1996 8 47–52
Herrman HC, Chang G, Flugherz BD, Mahoney PD Haemodynamic effects of sildenafil in men with severe coronary artery disease N Engl J Med 2000 342 1622–1626
Van Popele NM et alArterial stiffness as underlying disagreement between an oscillometric blood pressure monitor and a sphygmomanometer Hypertension 2000 36 484–488
Webb DJ, Freestone S, Allen MJ, Muirhead GJ Sildenafil citrate and blood pressure lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist Am J Cardiol 1999 83 21C–28C
Philips BG et alSympathetic activation by sildenafil Circulation 2000 102 3068–3073
Williams D, Feely J Initial uptake of sildenafil in general practice Eur J Clin Pharmacol 2001 56 912–914
Hedner T et alEnhanced blood pressure lowering effect in hypertensivepatients on combined sildenafil and lercanidipine treatment. (Abstract) J Hypertens 2000 18 S165
Stein RA Cardiovascular response to sexual activity Am J Cardiol 2000 86 (Suppl) 27F–29F
El Sakka AI, Lue TF Does a heart attack mean the end of sexual life? ACC Educational Highlights 1996 Winter 6–9
Kimmel SE Sex and myocardial infarction: an epidemiologic perspective Am J Cardiol 2000 86 (Suppl) 10F–13F
Mahmud A, Feely J Favourable effects on arterial wave reflection and pulse pressure amplification of adding angiotensin II receptor blockade in resistant hypertension J Hum Hypertens 2000 14 (Suppl) S41–S46
Chen CH et alDifferent effects of fosinopril and atenolol on wave reflection in hypertension Hypertension 1995 25 1034–1041
Ting CT et alArterial haemodynamics in human hypertension: effects of adrenergic blockade Circulation 1991 84 1099–1057
Wallis RM, Corbin JD, Francis SH, Ellis P Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function and contractile response of trabeculae cornae and aortic rings in vitro Am J Cardiol 1999 83 3C–12C
Yagimima T et alEffect of glyceryl trinitrate on peripheral arteries alters left ventricular hydraulic load in man Cardiov Res 1986 20 153–160
Webb DJ et alSildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in malepatients with stable angina J Am Coll Cardiol 2000 36 25–31
Stief CG et alEffects of sildenafil on cAMP and cGMP levels in isolated human cavernous and cardiac tissue Urology 2000 55 146–150
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mahmud, A., Hennessy, M. & Feely, J. Effect of sildenafil on blood pressure and arterial wave reflection in treated hypertensive men. J Hum Hypertens 15, 707–713 (2001). https://doi.org/10.1038/sj.jhh.1001244
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1001244
Keywords
This article is cited by
-
Effects of chronic type 5 phosphodiesterase inhibition on penile microvascular reactivity in hypertensive patients with erectile dysfunction: a randomized crossover placebo-controlled trial
Journal of Human Hypertension (2021)
-
Phosphodiesterase type 5 inhibitors and kidney disease
International Urology and Nephrology (2015)
-
Phosphodiesterase inhibition in heart failure
Heart Failure Reviews (2009)
-
PDE5 inhibitors and pulmonary hypertension
Current Sexual Health Reports (2008)
-
Phosphodiesterase 5 inhibition in essential hypertension
Current Hypertension Reports (2008)